Merck CEO announces structure and global leadership team for new Merck
August 31, 2009
In a press release statement, Richard T. Clark, chairman, president and chief executive officer of Merck & Co., Inc. announced a new organizational structure and named top management and senior leaders for Merck effective upon completion of the merger of Merck & Co., Inc. and Schering-Plough Corporation. The new structure will build on the combined strengths of Merck and Schering-Plough to create a more customer-focused, innovative and diversified global health care company positioned to capitalize on the greatest opportunities for growth. Animal Health and Consumer Health Care will operate as separate business units reporting to Mr. Clark. The new company will integrate across its divisions to take advantage of the significant growth opportunities in three key areas: emerging markets, biologics and vaccines. The company also will create new franchises focused on Women''s Health and Endocrine, and Mature Brands. The new Merck will benefit from the unparalleled industry experience of senior leaders from both Schering-Plough and Merck. The leaders named by Mr. Clark will serve on the company''s new Executive Committee. They, in turn, named the executives who will lead their divisional and functional teams at the new Merck. About 40 percent of Schering-Plough''s senior leaders will be part of the newly combined company in executive roles. As was indicated at the time of the merger announcement, a substantial majority of Schering-Plough employees will remain with the combined company. The new Merck will have five primary divisions: Global Human Health; Animal Health; Consumer Health Care; Merck Research Laboratories; and Merck Manufacturing. Each division and global support function leader will be a member of the new Merck Executive Committee and will report directly to Mr. Clark.